ORAOV1 Antikörper
-
- Target Alle ORAOV1 Produkte
- ORAOV1 (Oral Cancer Overexpressed 1 (ORAOV1))
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser ORAOV1 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA
- Aufreinigung
- Purified
- Immunogen
- ORAV1 antibody was raised in Rabbit using synthesized peptide derived from internal of human ORAV1 as the immunogen
- Isotyp
- IgG
-
anti-Oral Cancer Overexpressed 1 (ORAOV1) (Internal Region) antibody
ORAOV1 Reaktivität: Human, Ratte WB, ELISA, IF, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Oral Cancer Overexpressed 1 (ORAOV1) (Center) antibodyORAOV1 Reaktivität: Human WB, IF, IHC, IC Wirt: Kaninchen Polyclonal unconjugated
anti-Oral Cancer Overexpressed 1 (ORAOV1) (Internal Region) antibodyORAOV1 Reaktivität: Human WB, ELISA, IF, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Oral Cancer Overexpressed 1 (ORAOV1) (AA 81-130) antibodyORAOV1 Reaktivität: Human WB, ELISA Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
- WB: 1:500-1:1000, ELISA: 1:10000
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Konzentration
- Lot specific
- Buffer
- PBS (without Mg2+ and Ca2+), pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Handhabung
- Avoid repeated freeze/thaw cycles
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store in small aliquots at -20 °C
-
- Target
- ORAOV1 (Oral Cancer Overexpressed 1 (ORAOV1))
- Andere Bezeichnung
- ORAV1 (ORAOV1 Produkte)
- Synonyme
- TAOS1 antikoerper, 2210010N10Rik antikoerper, oral cancer overexpressed 1 antikoerper, ORAOV1 antikoerper, Oraov1 antikoerper
-
